1 RTI International, Research Triangle Park, North Carolina, USA.
2 Centers for Disease Control and Prevention and United States Public Health Service, Atlanta, Georgia, USA.
Qual Health Res. 2017 Nov;27(13):2071-2080. doi: 10.1177/1049732317732027. Epub 2017 Oct 3.
Our study sought to explore the actual and potential roles of patients, physicians, and pharmacists, as well as their shared challenges and opportunities, in improving the safety of medication use during pregnancy. We conducted virtual focus groups with 48 women and in-depth interviews with nine physicians and five pharmacists. Qualitative analysis revealed that all three groups of participants reported "playing it safe," the need for an engaged patient making informed decisions, challenges surrounding communication about pregnancy status, and a lack of patient-centric resources. Patients, physicians, and pharmacists are highly motivated to protect developing babies from potential harms of medication use during pregnancy while maintaining the patient's health. Strategic messaging could maximize the effectiveness of these interactions by helping physicians discuss the benefits and risks of medication use during pregnancy, pharmacists screen for pregnancy and counsel on medication safety, and patients using medications to share pregnancy intentions with their providers pre-pregnancy.
我们的研究旨在探讨患者、医生和药剂师的实际和潜在作用,以及他们在改善妊娠期间用药安全性方面所面临的共同挑战和机遇。我们对 48 名女性进行了虚拟焦点小组讨论,并对 9 名医生和 5 名药剂师进行了深入访谈。定性分析显示,所有三组参与者都报告了“谨慎行事”的做法,即需要一个积极参与并做出知情决策的患者,这涉及到沟通妊娠状况方面的挑战,以及缺乏以患者为中心的资源。患者、医生和药剂师都非常有动力保护发育中的婴儿免受妊娠期间用药潜在危害的影响,同时保持患者的健康。策略性信息传递可以通过帮助医生讨论妊娠期间用药的益处和风险、药剂师筛查妊娠并提供用药安全性咨询、以及正在使用药物的患者在怀孕前与提供者分享怀孕意愿,从而最大限度地提高这些互动的效果。